BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paquin-Proulx D, Sandberg JK. Persistent Immune Activation in CVID and the Role of IVIg in Its Suppression. Front Immunol 2014;5:637. [PMID: 25566250 DOI: 10.3389/fimmu.2014.00637] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 de Lollo C, de Moraes Vasconcelos D, da Silva Oliveira LM, de Oliveira Titz T, Carneiro-Sampaio M, Jacob CM, da Silva Duarte AJ, Sato MN. Impaired CD8(+) T cell responses upon Toll-like receptor activation in common variable immunodeficiency. J Transl Med 2016;14:138. [PMID: 27188997 DOI: 10.1186/s12967-016-0900-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
2 Cavaliere FM, Prezzo A, Conti V, Bilotta C, Pulvirenti F, Iacobini M, Quinti I. Intravenous immunoglobulin replacement induces an in vivo reduction of inflammatory monocytes and retains the monocyte ability to respond to bacterial stimulation in patients with common variable immunodeficiencies. International Immunopharmacology 2015;28:596-603. [DOI: 10.1016/j.intimp.2015.07.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
3 Abbott JK, Gelfand EW. Common Variable Immunodeficiency: Diagnosis, Management, and Treatment. Immunol Allergy Clin North Am 2015;35:637-58. [PMID: 26454311 DOI: 10.1016/j.iac.2015.07.009] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
4 Mormile I, Punziano A, Riolo CA, Granata F, Williams M, de Paulis A, Spadaro G, Rossi FW. Common Variable Immunodeficiency and Autoimmune Diseases: A Retrospective Study of 95 Adult Patients in a Single Tertiary Care Center. Front Immunol 2021;12:652487. [PMID: 34290696 DOI: 10.3389/fimmu.2021.652487] [Reference Citation Analysis]
5 Jindal AK, Rawat A, Sharma A, Dogra S, Suri D, Singh S. Psoriasis: An Unusual Autoimmune Manifestation in a Boy with Common Variable Immunodeficiency. Indian Dermatol Online J 2017;8:292-4. [PMID: 28761856 DOI: 10.4103/2229-5178.209610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
6 Azizi G, Hafezi N, Mohammadi H, Yazdani R, Alinia T, Tavakol M, Aghamohammadi A, Mirshafiey A. Abnormality of regulatory T cells in common variable immunodeficiency. Cellular Immunology 2017;315:11-7. [DOI: 10.1016/j.cellimm.2016.12.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
7 Valizadeh A, Yazdani R, Azizi G, Abolhassani H, Aghamohammadi A. A Comparison of Clinical and Immunologic Phenotypes in Familial and Sporadic Forms of Common Variable Immunodeficiency. Scand J Immunol 2017;86:239-47. [PMID: 28805315 DOI: 10.1111/sji.12593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
8 Sánchez-Ramón S, Dhalla F, Chapel H. Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy. Front Immunol 2016;7:317. [PMID: 27597852 DOI: 10.3389/fimmu.2016.00317] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
9 Prezzo A, Cavaliere FM, Milito C, Bilotta C, Iacobini M, Quinti I. Intravenous immunoglobulin replacement treatment reduces in vivo elastase secretion in patients with common variable immune disorders. Blood Transfus 2019;17:103-11. [PMID: 30036181 DOI: 10.2450/2018.0043-18] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Megna M, Pecoraro A, Balato N, Villani A, Crescenzi L, Balato A, Spadaro G. Psoriasis in a cohort of patients with common variable immunodeficiency. Br J Dermatol 2019;180:935-6. [PMID: 30414274 DOI: 10.1111/bjd.17408] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
11 Tsinti G, Makris D, Germenis AE, Speletas M. Persistent Activation of Innate Immunity in Patients with Primary Antibody Deficiencies. J Immunol Res 2020;2020:8317671. [PMID: 33274244 DOI: 10.1155/2020/8317671] [Reference Citation Analysis]
12 Cavaliere FM, Prezzo A, Bilotta C, Iacobini M, Quinti I. The lack of BTK does not impair monocytes and polymorphonuclear cells functions in X-linked agammaglobulinemia under treatment with intravenous immunoglobulin replacement. PLoS One 2017;12:e0175961. [PMID: 28422989 DOI: 10.1371/journal.pone.0175961] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
13 Paquin-Proulx D, Barsotti NS, Santos BAN, Marinho AKBB, Kokron CM, Carvalho KI, Barros MT, Kalil J, Nixon DF, Kallas EG. Inversion of the Vδ1 to Vδ2 γδ T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion. Medicine (Baltimore) 2016;95:e4304. [PMID: 27472706 DOI: 10.1097/MD.0000000000004304] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
14 Prezzo A, Cavaliere FM, Bilotta C, Iacobini M, Quinti I. Intravenous immunoglobulin replacement treatment does not alter polymorphonuclear leukocytes function and surface receptors expression in patients with common variable immunodeficiency. Cell Immunol 2016;306-307:25-34. [PMID: 27264689 DOI: 10.1016/j.cellimm.2016.05.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
15 Gullo I, Costa C, Silva SL, Ferreira C, Motta A, Silva SP, Ferreira RD, Rosmaninho P, Faria E, Costa JTD, Câmara R, Gonçalves G, Santos-Antunes J, Oliveira C, Machado JC, Carneiro F, Sousa AE. The Dysfunctional Immune System in Common Variable Immunodeficiency Increases the Susceptibility to Gastric Cancer. Cells 2020;9:E1498. [PMID: 32575504 DOI: 10.3390/cells9061498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ghorbani M, Fekrvand S, Shahkarami S, Yazdani R, Sohani M, Shaghaghi M, Hassanpour G, Mohammadi J, Negahdari B, Abolhassani H, Aghamohammadi A. The evaluation of neutropenia in common variable immune deficiency patients. Expert Rev Clin Immunol 2019;15:1225-33. [PMID: 31592698 DOI: 10.1080/1744666X.2020.1677154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
17 Agostini C, Blau IW, Kimby E, Plesner T. Prophylactic immunoglobulin therapy in secondary immune deficiency - an expert opinion. Expert Rev Clin Immunol 2016;12:921-6. [PMID: 27415820 DOI: 10.1080/1744666X.2016.1208085] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
18 Callery EL, Morais CLM, Paraskevaidi M, Brusic V, Vijayadurai P, Anantharachagan A, Martin FL, Rowbottom AW. New approach to investigate Common Variable Immunodeficiency patients using spectrochemical analysis of blood. Sci Rep 2019;9:7239. [PMID: 31076587 DOI: 10.1038/s41598-019-43196-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
19 Turpin D, Furudoi A, Parrens M, Blanco P, Viallard JF, Duluc D. Increase of follicular helper T cells skewed toward a Th1 profile in CVID patients with non-infectious clinical complications. Clin Immunol. 2018;197:130-138. [PMID: 30219667 DOI: 10.1016/j.clim.2018.09.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
20 Quinti I, Mitrevski M. Modulatory Effects of Antibody Replacement Therapy to Innate and Adaptive Immune Cells. Front Immunol 2017;8:697. [PMID: 28670314 DOI: 10.3389/fimmu.2017.00697] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
21 Azizi G, Abolhassani H, Asgardoon MH, Alinia T, Yazdani R, Mohammadi J, Rezaei N, Ochs HD, Aghamohammadi A. Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management. Expert Review of Clinical Immunology 2016;13:101-15. [DOI: 10.1080/1744666x.2016.1224664] [Cited by in Crossref: 33] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
22 Polito R, Nigro E, Pecoraro A, Monaco ML, Perna F, Sanduzzi A, Genovese A, Spadaro G, Daniele A. Adiponectin Receptors and Pro-inflammatory Cytokines Are Modulated in Common Variable Immunodeficiency Patients: Correlation With Ig Replacement Therapy. Front Immunol 2019;10:2812. [PMID: 31827477 DOI: 10.3389/fimmu.2019.02812] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
23 Farrugia A, Visentini M, Quinti I. Editorial: Immunoglobulin Therapy in the 21st Century - the Dark Side of the Moon. Front Immunol 2015;6:436. [PMID: 26379671 DOI: 10.3389/fimmu.2015.00436] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]